Published by News Medical
Feb 16, 2024
An excerpt from the original article is posted below:
Aventa Genomics is a joint venture between Arima Genomics and Protean BioDiagnostics. What synergies between these two companies led to the formation of Aventa Genomics, and how do these synergies drive the company’s innovation and research?
The two companies have complementary competencies. Arima Genomics is fundamentally a technology company, and Protean BioDiagnostics is a clinical laboratory testing company.
“Aventa FusionPlus is a genome-wide test and bioinformatically filters to report variants in 361 genes that are potentially actionable in solid tumors.”